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Abstract
Obstructive sleep apnoea syndrome (OSAS) is a frequently occurring disease
with multiple co-morbidities. Left untreated, OSAS has important health
and socioeconomic consequences but effective therapies are available.
Consequently, its diagnosis is important. The usual pathway for a reliable
diagnosis includes detailed sleep history, clinical examination followed by
attended full polysomnography (PSG) which is the reference standard for
the diagnosis of respiratory sleep disorders. This approach is a time and
resource consuming process given its increasing demand. Therefore, several
less elaborate sleep portable monitoring (PM) devices have been developed for
the diagnosis of OSAS. Up to now however, no single device has been widely
accepted as an alternative to PSG because of important limitations such as the
lack of sleep/wake status assessment, the lack of detection of arousals during
sleep (an important contribution in the calculation of the respiratory arousal index,
an index of ...
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1 
THESIS SUMMARY 
 
Obstructive sleep apnoea syndrome (OSAS) is a frequently occurring 
disease with multiple co-morbidities. Left untreated, OSAS has 
important health and socioeconomic consequences but effective 
therapies are available. Consequently, its diagnosis is important. The 
usual pathway for a reliable diagnosis includes detailed sleep history, 
clinical examination followed by attended full polysomnography (PSG) 
which is the reference standard for the diagnosis of respiratory sleep 
disorders. This approach is a time and resource consuming process given 
its increasing demand. Therefore, several less elaborate sleep portable 
monitoring (PM) devices have been developed for the diagnosis of 
OSAS. Up to now however, no single device has been widely accepted 
as an alternative to PSG because of important limitations such as the lack 
of sleep/wake status assessment, the lack of detection of arousals during 
sleep (an important contribution in the calculation of the respiratory 
arousal index, an index of disease severity, and a criteria used for 
respiratory events - hypopnoea- scoring). 
This thesis focuses on the added value of mandible movement (MM) 
assessment in a new type of PM system, the Somnolter®, for the 
detection and diagnosis of sleep disordered breathing (SDB) in adults. 
Mouth opening is a common observation during sleep in patients 
suffering from sleep-disordered breathing and is different from mandible 
posture during sleep in healthy adults.  
We demonstrated that this approach allows for a better accuracy in the 
detection of SDB in an automated analysis, both in men and women. The 
first finding was a better detection of hypopnoea when compared to a 
PM without MM analysis, thanks to the associated salient mandible 
movement (SMM). SMM has been used as a surrogate for respiratory 
arousal. We also found that this method improved the accuracy of the 
2 
apnoea hypopnoea index calculation (AHI), the most important index in 
SDB severity assessment. The calculation of this AHI depends on the 
total sleep time (TST) which is the denominator. Thus, the second 
important finding of this work was the sleep/wake state assessment 
which provided the TST. Thirdly, we were able to demonstrate that 
mandible behaviour under CPAP treatment was similar to the one found 
in healthy subjects. Typically, this translates into a mouth in a more 
closed position without repeated downward excursions. Indeed, 
mandible downward excursions and breathing effort are highly 
correlated. The fourth finding was that the MM analysis might be an 
interesting non-invasive marker of breathing effort during sleep and is 
less sleep disruptive than the invasive conventional method (oesophageal 
pressure). 
A fifth finding was the feasibility of successfully training scorers for the 
visual recognition of these patterns. Specific mandible patterns have 
been isolated, described and correctly identified in active wakefulness, in 
quiet sleep, in quiet wakefulness, during obstructive and central apnoea 
and hypopnoea, during mixed apnoea, during snoring and respiratory 
related arousals.  
The addition of MM assessment to a PM device allows for the 
identification of sleep/wake state, sleep micro-fragmentation and the 
detection of excessive breathing effort in obstructive respiratory events. 
For these reasons, we conclude that the Somnolter® is potentially an 
interesting alternative to PSG in the management of SDB in adults.  
  
3 
ABBREVIATIONS LIST 
 
AHI : apnoea hypopnoea index 
AHISMN : number of PSG events in Somnolter® sleep periods / TSTSMN 
aLOW : average of the mandible lowering during sleep  
aAMPL : average amplitude of the oscillations of the mandible 
movement signal  
ArI : arousal index  
ASDA : American Sleep Disorders Association 
AW : active wakefulness 
B&A : Bland and Altman  
BMI : body mass index 
BP : blood pressure 
BzD : benzodiazepines 
CAH : central apnoea hypopnoea 
CI : confidence interval 
COPD : chronic obstructive pulmonary disease 
CPAP : continuous positive airway pressure 
CPSG : PSG recording under CPAP treatment 
DPSG : diagnostic PSG recording 
ECG : electrocardiogram 
EEG : electroencephalogram 
EMG : electromyogram 
EOG : electrooculogram 
GEE : a generalised estimating equation model 
HI : hypopnoea index 
HR : heart rate 
HTA : systemic arterial hypertension 
LR - : negative likelihood ratio 
LR + : positive likelihood ratio 
MA : mixed apnoea 
MExc : mandible inspiratory downward excursion 
MExca : mandible inspiratory downward excursion expressed in absolute 
value 
MExcr : mandible inspiratory downward excursion in percentage of the 
maximum mouth opening measured during the calibration 
MMAA : mandible movement automated analysis ((MposTe - MposTi) 
MM : mandible movement 
MMO : maximal mouth opening 
4 
Mpos Te : mandible position (Mpos) at end-expiratory time 
Mpos Ti : mandible position (Mpos) at end-inspiratory time 
MS : multiple sclerosis 
NAF : nasal airflow 
NP : nasal pressure 
NREM-sleep : non-rapid eye movement sleep 
OAH : obstructive apnoea hypopnoea 
OSA : obstructive sleep apnoea disease (the presence of sleep apnoea 
and hypopnoea, without symptoms) 
OSAS : obstructive sleep apnoea syndrome 
PAT : peripheral arterial tone  
Pes : oesophageal pressure 
PesTe : oesophageal pressure at end-expiratory time 
PesTi : oesophageal pressure at end-inspiratory time 
POS : body position 
PM : portable monitoring 
PSG : polysomnography 
PTT : pulse transit time  
QW/S : quiet wakefulness and quiet sleep 
RA : rheumatoid arthritis 
RDI : respiratory disturbance index 
REM-sleep : rapid eye movement sleep 
RERA : respiratory related arousal 
SDB : sleep disorders breathing 
Se : sensitivity 
SMM : salient mandible movement 
SMN : Somnolter® 
SMM-RDI : respiratory disorder index with MMAA 
Sp : specificity 
SpO2 : pulse oximetry for the oxygen saturation 
SL_15PSG : sleep latency provided by the PSG: time in minutes between 
the START time and the first sleep period (including sleep stage 1) 
lasting 15 consecutive minutes of sleep 
SL_PSG : sleep latency provided by the PSG: time in minutes between 
the START time and the first sleep period (including sleep stage 1) 
lasting one sleep 30-second epoch 
SL_15SMN : sleep latency provided by the SMN: time in minutes between 
the START time and the first sleep period (including sleep stage 1) 
lasting 15 consecutive minutes of sleep 
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SL_SMN :  sleep latency provided by the SMN: time in minutes between 
the START time and the first sleep period (including sleep stage 1) 
lasting one sleep 30-second epoch 
SS : sleep snoring 
SWS : slow-wave-sleep (or stage NREM N3) 
TDT : total dark time 
TMO : total mouth opening 
TST : total sleep time 
TSTPSG : total sleep time provided by the PSG 
TSTSMN : total sleep time provided by the Somnolter® 
UA : upper airway 
UAR : upper airway resistance  
UARS : upper airway resistance syndrome 
W : wakefulness 
WAc : wrist actigraphy  
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Chapter 1 
Introduction : Sleep disordered breathing diseases and 
mandible movement study in the context 
of a new portable monitoring device 
 
INTRODUCTION 
 
This thesis is devoted to the assessment of the utility of a new type of portable 
monitoring system (Somnolter®) for the detection and diagnosis of sleep disordered 
breathing (SDB) in adults. The unique feature of this system is the provision of 
mandible movement assessment. The underlying hypothesis is that mandible 
movements are both passive and active in SDB, guided by underlying, and until 
now incompletely explored, neurological pathways which could provide important 
information on pathophysiological and therapeutic aspects of the sleep apnoea 
syndrome. 
SDB and particularly the obstructive sleep apnoea syndrome (OSAS) are highly 
prevalent and are associated with a high level of morbidity related to sleepiness as 
well as an increased risk of cardiovascular diseases. The diagnosis is therefore 
important. The usual pathway for a reliable diagnosis includes detailed sleep 
history, clinical examination, followed by attended full polysomnography (PSG), 
which is currently the reference standard for the diagnosis of respiratory sleep 
disorders. The recording is scored by a trained technician and validated by a sleep 
physician. This approach is a time and resource consuming process given its 
increasing demand. Therefore, strategies are explored to define who should 
undergo a PSG and who could be assessed using alternative diagnostic methods. In 
this context, portable monitoring (PM) devices have been developed for the 
assessment of SDB. Up to now however, no single device has been widely 
accepted as an alternative to PSG. 
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By demonstrating the specificities of the mandible movement signal during sleep, 
this thesis focuses on the added value of this new approach in the development of 
PM devices. Important avenues in the assessment of patients with suspected SDB 
will be explored : 
• screening with the validation of the automated detection of the respiratory 
events by the Somnolter®, 
• the recognition of the salient mandible movement (SMM) associated with 
respiratory arousals, 
• sleep-wake status assessment, 
• the mandible movement under continuous positive airway pressure (CPAP) 
treatment and the rationale for developing an auto-CPAP device guided by the 
mandible movement,  
• the association between MM and breathing effort assessed by oesophageal 
pressure swings during obstructive respiratory events.  
 
1. Sleep disordered breathing 
 
SDB encompasses a variety of disorders. These are defined according to the type of 
respiratory events found during a polysomnographic recording. The various 
respiratory events definitions and methods used to identify them are detailed in 
Annex 1.1 
The pattern of SDB is typically a cyclical repetition of breathing events (apnoea or 
hypopnoea) and hyperventilation. The repetition of obstructive apnoea and 
hypopnoea results in oscillations of arterial blood gas levels and sleep 
fragmentation. Obstructive events are secondary to partial or complete collapse of 
one or several parts of the upper airway (UA), resulting in continued breathing 
effort but inadequate ventilation. The termination of these obstructive events is 
usually associated with a cortical arousal, favouring reopening of the UA. 
Resuming of breathing is associated with loud snoring, normalizing oxygen blood 
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saturation and often overshooting ventilation. On the other hand, central events are 
characterized by diminished or absent breathing effort, in an intermittent or cyclical 
fashion, often due to central nervous system or cardiac dysfunction. Resuming of 
breathing is also characterized by overshooting ventilation. The presence of 
snoring is often observed and expresses the fact that at least, at the end of the 
central apnoea, a relative obstruction has taken place. 
1.1. Epidemiology of SDB  
 
There is a large body of research and literature available in the field of SDB 
epidemiology. SDB includes two main syndromes – central and obstructive sleep 
apnoea syndrome. OSAS is much more frequent.2 It is associated with multiple co-
morbidities. In western countries, obstructive sleep apnoea defined by an apnoea-
hypopnoea index (AHI) > 5/hour without reference to any symptoms (OSAS 
usually refers to an abnormal AHI with associated symptoms such as sleepiness) 
has a prevalence of 24 % in men and 9 % in women in the adult poupulation.3 The 
prevalence of moderate to severe OSAS (apnoea hypopnoea index > 15/h) is 9 % 
and 4 % in adult men and women respectively. This high prevalence is variable and 
linked to ethnic or co-morbid factors, particularly obesity which is the main 
predisposing factor. The consequences of OSAS are important in terms of health 
(cardiovascular effects4 such as hypertension, stroke5,6, daytime sleepiness linked 
to higher occupational and traffic accidents occurrence7) and socio-economic 
aspects. Treating OSAS allows a significant reduction in cardiovascular 
complications8 as well as reduced accidents linked to excessive daytime sleepiness, 
particularly among car drivers.9 
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1.2. Physiopathology 
 
The physiopathology of obstructive respiratory events during sleep is complex and 
some of its aspects are beyond the scope of this thesis.10 However, as discussed 
above, these events are invariably associated with a closure or reduced calibre of 
the UA.10,11 At the level of the oropharynx, there is susceptibility of the UA to 
closure due to the absence of rigid airway support. In normal non-obese subjects 
however, in passive conditions (no muscle activity), the UA is normally patent and 
requires about -5 cmH2O intraluminal pressure (the so-called critical pressure) to 
collapse.12 At or below the critical pressure, inspiratory airflow ceases due to 
closure of the pharyngeal segment of the UA. Accordingly, it is important to 
analyse the anatomical and physiological factors that influence the UA lumen cross 
sectional area and the critical pressure during the respiratory cycle. These are: 
- the UA lumen cross sectional area in passive conditions (i.e. in static conditions, 
without any muscle activity); 
- the upper airway collapsibility in passive conditions; 
- the negative intraluminal pressure during the inspiratory phase of the respiratory 
cycle (that is in dynamic conditions); 
- the activity of the UA dilator muscles. 
At any time, the patency of the UA is the result of the balance between the UA 
dilator muscle activity and the 3 factors which are susceptible to reduce the UA 
cross sectional area. We first discuss these 3 factors.  
In passive conditions (no muscle activity), the UA lumen cross sectional area is 
influenced by anatomical factors, either constitutional or acquired. Obesity is the 
main acquired predisposing factor for OSAS.13 It is associated with an increased 
amount of adipose tissue surrounding the pharyngeal airway within the limited 
maxillo-mandible space, leading to its narrowing. Other anatomical characteristics 
such as hypomaxillia,14 retrognathia,15 micrognathia,16 macroglossia, hypertrophied 
tonsils or adenoids are also associated with a reduced UA cross sectional area. The 
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angle between the neck and the head17 as well as the body position are other factors 
influencing the passive UA dimensions. During sleep, the weight of the mandible 
could contribute to its posterior displacement as well as that of the tongue, 
particularly when lying in the supine position. Finally, lung volume and pharyngeal 
lumen area are directly related such that reduced lung volumes lead to reduced UA 
cross sectional area.18 Since abdominal obesity is associated with reduced 
functional residual capacity, this also contributes to reduce the UA cross sectional 
area in obese patients. 
By eliminating the neural control mechanisms during anaesthesia and total 
paralysis, Isono et al. could demonstrate that OSAS patients not only had 
structurally narrower but also more collapsible UA than age-matched and BMI-
matched non-OSAS patients.19 As discussed above, reduced lung volumes are 
associated with reduced UA cross sectional area.18 But reduced lung volumes due 
to obesity or other factors also compromise UA patency because of its association 
with increased UA collapsibility.13 
The negative intraluminal pressure within the UA is dependent on the inspiratory 
flow but also on the resistance of the airway above the pharynx. Accordingly, nasal 
obstruction may negatively influence the pharyngeal airway patency. 
In case of increased susceptibility for UA collapse, the latter can only be avoided 
by an increased activity of the UA dilator muscles or alternatively by applying a 
positive UA intraluminal pressure which is the rationale for continuous positive 
airway pressure (CPAP), the gold standard therapy for OSAS. Most OSAS patients 
have an anatomically narrow UA with compensatory increased pharyngeal dilator 
muscle activity that succeeds to maintain airway patency during wakefulness,20 but 
fails to do so during sleep.21 Individual variability in the ability of UA dilator 
muscles to maintain UA patency exists and is the basis for different phenotypical 
characteristics of sleep-disordered breathing events. Accordingly, respiratory 
events associated with reduced UA patency during sleep vary from simple snoring, 
upper airway resistance syndrome (UARS), obstructive hypopnoea to obstructive 
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sleep apnoea. Moreover, episodes of partial or full airway closure can occur in the 
same patient across the night. Although reduced UA patency is critical in the 
pathogenesis of OSAS, respiratory control instability during sleep which is out of 
the scope of this thesis also plays an important role leading either to central or 
obstructive events, depending on the UA characteristics discussed above.10,11 
The UA partakes in vital functions such as swallowing and breathing. The 
coordination of the activity of the various UA muscles for achieving these 
functions is complex. The act of breathing is orchestrated by the respiratory centres 
which in turn are influenced by feed-back information received from various 
receptors. Both central and obstructive events usually occur as part of a periodic 
breathing pattern under the control of a permanently oscillating system comprising 
many players such as peripheral as well as central chemoreceptors sensing arterial 
blood gases (PaO2 and PaCO2), the cardiovascular system, and the respiratory 
centres.10,11 
In normal conditions, UA dilator muscles and inspiratory muscles act in a 
coordinated manner. The respiratory centres receive afferent information from 
various receptors and command the phasic inspiratory contraction of the UA dilator 
muscles such that it arises 50-100 msec before that of the diaphragm and the other 
inspiratory muscles acting on the thoracic cage. The most important and most 
studied UA dilator muscle is the genioglossus (GG). The activities of the GG and 
its motor nerve (originating from the XIIth cranial nerve pair, the hypoglossal 
nerve) are phasic (inspiratory bursts) on a tonic permanent state.22,23 All stimuli that 
increase ventilation also tend to increase UA patency due to an increase in the 
phasic contraction of the UA dilator muscles. Accordingly, hypoxia and 
hypercapnia which are the main stimuli for ventilation also increase the GG phasic 
contraction.24, 25 This counteracts the increasingly negative pressure induced by the 
contraction of the inspiratory muscles26 in these conditions and prevents UA 
closure in normal subjects in both the awake and sleep states.  
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The UA dilator muscles activity is also influenced by mechanoreceptors located in 
the UA wall. Afferences go up to the brainstem through the glossopharyngeal IXth 
cranial nerve. 
Efferences to the GG go through the hypoglossal motor nucleus. These 
mechanoreceptors are stimulated by lower (more negative) intraluminal pressures 
and allow the UA dilator muscles to counteract this negative pressure for 
maintaining UA patency10 (see figure 1). 
In subjects with OSAS, UA dilator muscles become unable to maintain UA 
patency during sleep. The GG activity (both tonic and phasic activities) decreases 
prior to the respiratory obstructive event.27 This decreased activity may trigger the 
obstructive respiratory event by decreasing the UA patency. However, during the 
obstructive event, the GG phasic activity progressively increases, as demonstrated 
by EMG studies, reaching the highest amplitude before the termination of the 
obstructive event.22  UA mechanoreceptors are likely responsible for the gradual 
increase in GG phasic activity during an obstructive apnoeic event. Moreover, it 
has been demonstrated that this increased phasic activity is directly related to 
oesophageal pressure swings during non-REM sleep obstructive apnoeic events,28 
and mirrors the phasic activity of the diaphragm29 or inspiratory intercostals30 
during these events. This intra-event gradual increase in phasic activity of the GG 
drastically fall when obstructive apnoeas are treated either by CPAP31,32 or a 
mandibular advancement device,33 suggesting that it is a direct consequence of 
obstructive events. 
Along with the UA mechanoreceptors, nose receptors also detect negative 
intraluminal airway pressure (in case of increased nasal resistance or airflow) and 
send afferences through the trigeminal nerve (maxillary branch), inducing 
compensatory pharyngeal dilator muscle activation in the more collapsible 
regions.34 
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Figure 1: Non-invasive genioglossal EMG recording during NREM-sleep. Extracted from Sauerland 
E.K. and colleagues. 35 
A. Obese 42 year old patient with SAOS and hypoventilation syndrome during unobstructed 
breathing. Vigorous inspiratory genioglossal EMG bursts are present. 
B. Obese 60 year old patient with history of upper airway obstruction. Recording segment shows well 
defined inspiratory genioglossal EMG discharges during unobstructed respiration (respiration is 
monitored by oesophageal transducer). GG inspiratory bursts are pointed by an arrow, starting when 
inspiration begins. Calibrations: EEG: 100 µV; EMG: 200 µV; time in seconds. 
 
In awake healthy subjects, the tonic activity of the GG is markedly increased in the 
supine position,35-37 to counteract the posterior movement of the tongue due to its 
own gravity.  
Importantly, UA dilator activity and its reflex regulation are both influenced by the 
sleep/wake status. Indeed, the activity of the GG are reduced at sleep onset 
compared to wakefulness 38 and further so in REM sleep.22,38 Moreover, the reflex 
increase in phasic activity of the GG induced by more negative intraluminal 
pressure is attenuated during NREM sleep as compared to wake21 and even further 
during REM sleep. 22,39  
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In summary, anatomical features of the UA as well as the control of pharyngeal 
muscle tone across states of wakefulness and sleep are important to its patency and 
collapsibility. Sleep is associated with an increased susceptibility of the UA to 
collapse because of a fall in UA dilator muscle activity (mainly the tonic activity) 
secondary to loss of the “wakeful” neuronal input and insufficient compensatory 
response towards negative intraluminal pressure (the phasic activity which is 
coupled with respiration). The imbalance between UA dilator muscle activity and 
the other factors reducing UA cross sectional area during sleep is critically 
implicated in snoring, inspiratory flow limitation, airway closure and OSAS 
whereas there is a progressive increase in inspiratory muscle activity during these 
events. During a sleep related obstructive respiratory event, the phasic activity of 
the UA dilator muscles increases gradually in parallel with the inspiratory muscle 
activity, up to the event termination. 
1.3. Mandible movements during sleep in normal subjects and in OSAS 
 
The mandible is the anchor for many muscles inserted on the anterior wall of the 
pharynx, the hyoid bone or the maxilla. Among these muscles, some are UA 
dilators. 
The location and articulated integration of the mandible in the UA explain how it 
could move passively or secondary to the contraction of various muscles, leading 
to specific movement patterns during sleep in normal or disordered breathing. 
Some UA dilator muscles have insertions on the mandible, such as the GG and the 
geniohyoid muscles. The anatomy of the muscles from the cervico-mandibular 
region is illustrated in figure 2. Upper airway muscles exhibiting an inspiratory 
burst pattern are the GG, the laryngeal abductor (posterior cricoarytenoid), the 
geniohyoid, the tensor palatini, the stylopharyngeus, the styloglossus and the 
medial pterygoid muscles. 
By contracting, the GG generates tongue protrusion, an activity which promotes 
upper airway patency, which will induce a downward movement of the mandible.27 
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Other muscles like the anterior belly of the digastric could also play a role in 
maintaining UA patency as well as moving the mandible downward. 
  
 
Figure 2 : Muscles of the cervico-mandibular region. Pharyngeal dilator muscles inserted on the 
mandible are: the genioglossus (which is the ventral wall of the hypopharynx, inserting on the internal 
surface of the mandible) and the geniohyoid muscles. The hyoid bone lies ventral to the GG muscle 
and serves as a point of attachment for several muscles: the geniohyoid, the digastric, the thyrohyoid 
muscles. Submental electromyographical surface electrodes detect activity of: the GG, the 
geniohyoid, the anterior chief of the digastric, the mylohyoid, the plathysma muscles. As the GG 
muscle contraction, the mylohyoid, the geniohyoid and the digastric muscles act for mouth opening. 
Inspired from “Atlas d’anatomie humaine A.D.A.M. ®” Todd R. Olson. 2002.Translated by C. 
Fontaine. Ed. Pradel, 2012.  
 
In healthy subjects, the movements of the mandible are influenced by wakefulness 
and sleep. Miyamoto has depicted the influence of sleep, sleep stage and body 
position on mandible posture in healthy adults. He demonstrated that the proportion 
of time during which the mandible was in a near-closed position significantly and 
progressively decreased during sleep. Significantly more time was spent at wider 
mandible opening as non-rapid-eye-movement (NREM) sleep deepened, but body 
position had no significant influence on mandibular posture in these healthy 
subjects.40 
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Miyamoto also showed that the mandibular posture is more opened during sleep in 
patients with OSAS than in healthy adults, especially during NREM-sleep and in 
the supine position, and that mouth opening increases progressively during apnoeic 
episodes and decreases at the termination of those episodes.41 Hollowell and Suratt 
found that the mouths of patients with OSAS were open significantly more at end 
inspiration than at end expiration during the apnoea in both NREM and REM-
sleep. A mandible lowering occurred at the end of the apnoea (progressively 
increasing with every inspiration) in stage 2 and REM-sleep, both mouth opening 
in these stages were statistically different from equivalent mouth opening of 
normal subjects.27  
Mandibular opening at the end of expiration could narrow the upper airway 
(secondary to an inferior-posterior movement of the mandible), whereas opening at 
the end of inspiration could reflect efforts which is called the thoracic tug. As the 
UA is occluded or suboccluded, the contraction of the thoracic inspiratory muscles 
induces greater negative pressures into the thoracic cavity which in turn are 
associated with a longitudinal traction on the trachea and on ventro-lateral cervical 
soft tissues.42 The tracheal tug is thought to passively contribute to the downward 
movement of the mandible during the inspiratory phase of obstructed respiratory 
cycles. During these events, due to the closure of the UA, the dilator muscles see 
their posterior insertions locked on the anterior wall of the UA. Their shortening 
(particularly that of the GG) thus may result in a downward movement of the 
mandible. As the inspiratory phasic activity of the UA dilator muscles increases 
(simultaneously with increasing breathing effort) during the obstructive apnoeic 
events, so does the downward movement of the mandible during these events.  
The masseter is a jaw-closing muscle (figure 3). During sleep in healthy subjects, it 
has a reduced tonic activity and no inspiratory activity. A small phasic inspiratory 
activity has been described in the masseter of OSAS patients.27 In OSAS patients, 
at the termination of obstructive apnoeic events, the masseter and submental 
muscles contract (figure 4). 27,35,37,43 The contraction of the GG is necessary to 
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restore the UA permeability. The contraction of masticatory muscles - including 
the masseter - after the apnoea has been assumed to stabilize the mandible (an 
upward of the mandible without fully mouth closure).27, 43 Without this 
stabilisation, the GG contraction could generate a posterior movement of the 
mandible. The sequence of muscle recruitment at the end of the respiratory event 
therefore promotes UA patency (figure 4). We have called this closing movement 
of the mandible at the end of the apnoea the salient mandible movement (SMM).27, 
40, 41 
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Figure 3 : Illustration of the masticator muscles: 
masseter and medial pterygoid muscles, both 
innervated by the third branch of the Vth cranial 
nerve. Temporalis muscle is not showed. Inspired 
from “Atlas d’anatomie humaine A.D.A.M. ®” 
Todd R. Olson. 2002. Translated by C. Fontaine. 
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Figure 4: An obstructive respiratory event where chin and masseter electromyograms 
(EMG) illustrate the drop in tonic activity at the beginning of apnoea, with progressive 
increase in phasic (inspiratory) activity during the event. The contraction of the chin 
muscles (mainly the GG) and masseter is necessary to restore the UA patency. EOG: 
electro-oculogram with two EEG derivations (C3/A2 and O2/A1); Flow: nasal airflow; 
Pes:oesophageal pressure. Extracted from Hollowell and Suratt. 27 
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To summarise, during obstructive sleep respiratory event, a passive gradual 
lowering of the mandible occurs, characterized by an oscillating pattern (cyclical 
downward excursions of the mandible) linked to inspiratory effort that increases in 
amplitude during obstructive respiratory events, ending with a closing active 
movement of the mandible (figure 5). This oscillating pattern is absent during 
central respiratory events. These mandible movement patterns thus potentially 
provide meaningful information to recognize and classify SDB as will be discussed 
in this thesis.  
 
 
Figure 5: Typical mandible movement patterns occurring during sleep-related respiratory events: 
obstructive apnoea (a), central apnoea (b), mixed apnoea (c) and hypopnoea (d). The salient mandible 
movement (pointed by an arrow) appears at the end of the respiratory event, after oscillations of the 
mandible which are part of its definition.  
 
2. Portable monitoring  
 
Portable sleep apnoea monitoring devices, becoming less intrusive and self-
applicable, have been developed. As the access to the gold standard diagnostic test 
(full PSG) is limited, PM devices have been developed for the primary assessment 
of SDB. The validity of these alternatives to PSG remains disputed because of 
methodological concerns regarding their evaluation (comparison with the gold 
standard, studied populations, visual or automated analysis…). In the validation 
process of a PM, many factors must be considered, including its distinctive 
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features.  
 
2.1. PM classification   
 
The methods used for investigations of sleep-disordered breathing have been 
classified in 4 types by the American Sleep Disorders Association (ASDA)44 : 
• The type I is the standard PSG which includes : in-lab registration of minimum 
2 electroencephalography (EEG) derivations, submental electromyogram 
(EMG), electroculography (EOG), airflow, thoraco-abdominal movements, 
pulse oximetry for the oxygen saturation (SpO2) and electrocardiogram (ECG) 
under the supervision of a trained sleep medicine personnel. This procedure is 
called attended PSG.  
• The type II is similar to type I but without monitoring of the acquired signals 
by a technician. This procedure is usually called unattended or home PSG. 
• The Type III registers at least four parameters, including 2 ventilatory signals 
(airflow, respiratory movements), SpO2 and ECG or cardiac frequency. 
• Type IV registers one or two variables, generally SpO2 and/or nasal airflow. 
Accordingly, PM belongs to the category III or IV.  
 
2.2. Place and limitations of PMs in medical practice  
 
The literature on PMs is extensive and complex to analyse, due to the existence of 
different PM types and to the variability of the recording conditions (attended or 
not, at home or in the hospital setting). Results depend on the population studied 
and particularly the pre-test probability of having OSAS. Until the beginning of the 
2000s, the lack of standardisation of these methods (particularly types III and IV), 
the variability in measurement techniques and in their interpretation were identified 
as problematic. Furthermore, the lack of rigorous validation and cost/benefit 
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assessment were pointed in many reviews.44-48  In the recent years, many papers on 
the subject have been published. A Pubmed search on April, 2014 for the term « 
portable sleep monitoring » retrieved 472 references including 65 for the year 
2013. The role of PM in the assessment of OSAS has been studied in both the 
screening and diagnostic processes. 
Reviews on the place of PM research have led to the conclusion that a diagnosis of 
OSAS can be performed using this type of device providing certain conditions are 
met. These devices are reliable if they are used under the supervision of trained 
personnel for sleep medicine and if the subjects investigated have a high pre-test 
probability of suffering from sleep-disordered breathing, without any other sleep 
disorders or comorbidities.49,50  The high pre-test probability is estimated by the 
sleep medicine specialist and dependent on questionnaires or subjective 
appreciation. Many sleep disorders exist and the relative impact of mixed disorders 
in the general population is likely not negligible. Nevertheless, their respective 
impact on PM results are probably variable (e.a. the arousal linked to periodic limb 
movement, sleep speaking for our device...). The question of the place of these 
PMs in the screening of OSAS in older patients or patients with multiple co-
morbidities (e.a. cardiovascular disease in case of a PM using autonomic nervous 
activity study) and medications is also still open. 
However, used in the right setting, automated analysis applied to signals from PM 
might offer a significant gain in time with good diagnostic performance. 
  
As compared to PSG, most of type III PM have 2 major limitations.   
1. First, with PSG, the sleep-wake assessment provided by the EEG allows the 
calculation of an AHI using the total sleep time (TST) as denominator. The lack of 
sleep/wake assessment with most of type III or IV PM imposes the use of the time 
in bed (TIB) as denominator for the calculation of a respiratory disturbance index 
(RDI). This leads the RDI to be an underestimate of the AHI, the weight of the 
underestimation depending on the time spent awake during the night which 
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remains unknown with most PM. Accordingly, PM allowing to distinguish sleep 
and wake states would have a clear advantage.  
 
2. Second, most PMs are not able to detect arousals during sleep, hereafter 
designed as arousals. Indeed, arousals are defined on the basis of an EEG that is 
included only in type I or II methods. However, there is a potential for some PMs 
to detect surrogates for arousals. Detection of arousals is of importance for two 
reasons. 
• Arousals partake in the definition of hypopnoeas which includes the 
association of an airflow reduction as well as a desaturation and/or an 
arousal. Detection of hypopnoeas is essential in the staging of the disease 
since it influences the AHI index.  
• In the management of OSAS patients, the AHI is not the only 
polysomnographic outcome measure to predict health problems associated 
with OSAS. Excessive daytime sleepiness is related to the number of 
arousals. Here again, PMs able to detect respiratory arousals or surrogates 
and to calculate an arousal index (number of arousals per hour of sleep) 
would have an advantage. 
  
There are methodological limitations in the validation procedure of PMs. An event-
by-event analysis is preferable to correlate the respiratory events identification by 
each studied method. But generally, a separate analysis (PSG scorers are blinded to 
the PM signals) of the PSG and the PM recordings is recommended. In practice, 
this will lead to cumbersome steps in the procedure with many scorers and 
interventions.  
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2.3. Description of the method  
 
The originality of the Somnolter®, the type III PM studied in this thesis is the 
mandible movement analysis, a signal provided by the Jawsens® (Nomics, 
Belgium). The sensors are shown in figures 6 & 7. 
The mandible movement signal processing has been described by Senny et al.51,52 
This device includes two sensors (magnetically coupled resonant circuits, one 
transmitter and one receiver). The signal gives a specific pattern over time called 
the jaw activity (Jawac). Physical calibration is done by asking the patient to first 
close the mouth and then to fully open it. The Jawsens® (figure 6) is integrated into 
the multisignal analysis software provided by the Somnolter® (figure 7).  
The Somnolter® is a respiratory polygraphy including signals for : 
• nasal airflow (Protech nasal canula),  
• SpO2 (finger oximetry probe), 
• thoracic movements (respiratory impedance plethysmography belt), 
• body position 
• mid-sagittal mandible movement (MM) (Jawsens®).  
In adults, the mid-sagittal jaw movement analysis has been shown to be efficient 
for respiratory events detection51 and sleep/wake discrimination.52 
The future is the multi-physiological signal approach of respiratory disorders and 
sleep/wake assessment, combined for a better accuracy in the diagnostic approach. 
The scoring of the recordings could be totally automated or manual with the 
assistance of computer software. 
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Figure 6 : The Jawsens® : mandible sensors, each embedded 
in a small cylinder (7 mm diameter; 25 mm main axis), are 
placed perpendicularly to the medium line of the face, 
parallel to each other, one on the chin and the other on the 
forehead. The output voltage is a cubic function of the 
distance between them. The electronic circuit converts 
distance into voltage. The voltage is sampled at 10 Hz, 
digitally linearized and stored on a computer. The signal can 
be expressed either in absolute value (millimetre) or in 
normalized value (percentage of maximal mouth opening). 
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Figure 7 : The Somnolter® 
 
2.4. General limitations linked to the gold standard, the PSG. 
 
In the validation procedure of PM, some important aspects of the PSG must be kept 
in mind. 
The PSG is a physiological recording. But, almost all the recorded signals are 
uncalibrated and the visual scoring is based on pattern identification of qualitative 
signals. The sensors and recording equipment provided by manufacturers are not 
standardised.  
The current criteria used for stage sleep were defined fifty years ago to characterize 
sleep in normal individuals. The epochs duration is 30 seconds and the 
predominant state is used to define wakefulness or sleep and sleep stage. The 
scoring of abnormal respiratory events, in particular hypopnoea, relies on different 
definitions which could lead to different interpretations based on the definition 
used.  It is therefore important to detail the criteria and definitions used in both the 
PSG and the PM.    
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Despite the improvement of the technology and analysis used in PMs, the 
correlation between PSG and the PM (registered simultaneously) suffers from these 
limitations.  
 
CONCLUSION 
 
The aim of the present thesis is to assess the diagnostic and screening validity of a 
PM device in OSAS. This equipment (respiratory polygraphy; Somnolter®) does 
include a sensor evaluating the mouth opening (Jawsens®) and its specific 
behaviour over time. The apparatus will be validated against the diagnostic 
standard (PSG) in an attended and automated way. 
The salient mandible movement, as a surrogate for arousal, contributes to 
hypopnoea detection in an automated analysis combined with SpO2 and nasal 
airflow. The added value of the mandible movement automated analysis in the 
screening of OSAS is described in chapter 2. The validity of the device in men and 
women is detailed. Chapter 3 is dedicated to the sleep/wake state assessment by the 
automated scoring of the mandible movement. The mandible behaviour under 
CPAP treatment and its interest to therapeutic approach are depicted in chapter 4.  
After these first chapters using the automated analysis provided by the Somnolter®, 
a visual approach was chosen to explore the characteristics of mandible behaviour 
on the recordings. In chapter 5, we postulated that all the typical mandible patterns 
could be visually recognised on isolated Jawsens® recordings to identify active 
wakefulness, quiet wakefulness and quiet sleep, snoring, respiratory events and the 
presence of an associated effort (obstructive and mixed events). 
In chapter 6, we tested the hypothesis that the amplitude of the mandible movement 
during obstructive respiratory events is related to the magnitude of the inspiratory 
effort, as assessed by oesophageal pressure deflection.  
Finally, the respective advantages of the Somnolter® and 2 other methods included 
in PM devices that share interesting characteristics in the approach of SDB (the 
29 
peripheral arterial tone in the Watch-PAT and the pulse transit time) are discussed 
in chapter 7.  
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